Upgrade to SI Premium - Free Trial

Medtronic, Inc. (MDT) PT Lowered to $85 at UBS, Neutral Rating Maintained

June 4, 2026 9:51 AM
UBS analyst Priya Sachdeva lowered the price target on Medtronic, Inc. (NYSE: MDT) to $85.00 (from $90.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change